Summary
AMK Pharma has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low). No annual accounts have been filed with the National Bank.
Acts, filings and financial milestones
2023
10-11
Gazette deed
Appointment: Karim Amhamdi (statutory manager)Resignation: Karim Amhamdi (manager) · Registered office clause · Purpose change8 facts ▸
Gazette deed
Appointment: Karim Amhamdi (statutory manager)
Resignation: Karim Amhamdi (manager) · Registered office clause · Purpose change8 facts ▸
- Director appointment, Karim Amhamdi (statutory manager) (2 times)
- Registered office clause, “Région de Bruxelles-Capitale, 1030 Bruxelles(Schaerbeek),Rue Maurice des Ombiaux 3” (deed in French)
- General meeting, 16-10-2023
- Purpose change
- Director resignation, Karim Amhamdi (manager (not named in the articles))
- Other provision, “mise en conformité des statuts avec le CSA, article 39, §1, troisième alinéa loi du 23-03-2019 introduisant le CSA” (deed in French)
- Capital conversion, “compte de capitaux propres disponibles” (deed in French)
- Amendment of the articles
Gazette deed
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.